ResMed
Update in progressRMD (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Instruments & Supplies
ResMed Inc. develops, manufactures, and markets medical devices and cloud software to diagnose, treat, and manage respiratory disorders globally. It operates in two segments: Sleep and Breathing Health, and Residential Care Software. Key products include ApneaLink Air, NightOwl, EasyCare Tx, AirView, myAir, and a connectivity module. It also offers Brightree, HEALTHCAREfirst, MatrixCare, and MEDIFOX DAN solutions. Founded 1989; based in San Diego.
Company score
- Sentiment
- 0.41
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.11
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.44
- Governance
- 0.13
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.12
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.27
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Michael J. Farrell BE, MBA, SM
- Founded1989
- Employees11,370
- Websitewww.resmed.com
Identifiers
- ISINUS7611521078
- FIGIBBG000L4M7F1
- LEI529900T3QE5253CCXF22
- CUSIP761152107
- CIK0000943819